PRESS RELEASES

Date Title View
Toggle Summary Chimerix Awarded NIH Grant
Chimerix Awarded NIH Grant SAN DIEGO, CA, March 11, 2004 - Chimerix Inc., a biotechnology company developing orally available, targeted medicines for the treatment of smallpox, multi-drug resistant HIV and hepatitis virus infections, today announced that it has been awarded a Phase I Small Business
View HTML
Toggle Summary Chimerix Announces Licensing Deal
- Chimerix Obtains Rights to Cidofovir for Development of an Oral Drug to Treat Smallpox Infections -
View HTML
Toggle Summary CHIMERIX AWARDED $36.1M NIH Chimerix Awarded $36.1m NIH Grant To Develop Its Oral Drug For The Treatment Of Smallpox Infection
- Company Also Closes $3.1M Private Equity Financing
View HTML
Toggle Summary CHIMERIX, INC., ANNOUNCES APPOINTMENT OF EXPERT
- Company Currently Developing an Oral Drug for Sma
View HTML